NCT01383811

Brief Summary

The objective of this study is to determine the effects of adjunct exercise in treatment resistant depression. The central hypothesis for the research is that adjunct exercise with usual care in Treatment Resistant Depression (TRD) will have significant effects in improving the psychiatric symptoms in comparison to usual care alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

June 23, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 28, 2011

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

March 6, 2014

Status Verified

March 1, 2014

Enrollment Period

2 years

First QC Date

June 23, 2011

Last Update Submit

March 5, 2014

Conditions

Keywords

Treatment Resistant DepressionExercise

Outcome Measures

Primary Outcomes (1)

  • Change from baseline on Hamilton Rating Scale for Depression-17 item (HRSD17)score

    Hamilton Rating Scale for Depression-17 item (HRSD17, a well standardized measure of depression will be the primary measures of efficacy.

    Baseline, 6 weeks, and 12 weeks

Secondary Outcomes (3)

  • Reduction in baseline scores of clinical global impression severity

    Baseline, 6 weeks, and 12 weeks

  • Change from baseline on Beck Depression Inventory-II score

    Baseline, 6 weeks, 12 weeks

  • Change from baseline on Pittsburgh Sleep Quality Index (PSQI) global sleep quality score

    baseline, 6 weeks, 12 weeks.

Study Arms (2)

Moderate Intensity Aerobic Exercise

ACTIVE COMPARATOR
Other: Moderate Intensity Aerobic ExerciseOther: Wait-list

Wait List/Usual Care

OTHER

The subjects in this group will continue to receive the usual treatment that they were on at the time of enrollment through the wait list period of 12 weeks. Subsequently they will receive the 12 weeks of aerobic exercise program intervention

Other: Wait-list

Interventions

Individuals in this group will receive moderate intensity exercise in addition to their usual care (Medications+/-Psychotherapy). The moderate intensity exercise program will involve gradual progression in exercise intensity and duration. During the first 4 weeks, participants will attend 3 supervised sessions/week and will be asked to complete at least 2 unsupervised aerobic exercise sessions/week. From weeks 5-8 the number of supervised sessions will be 2/week with at least 3 unsupervised aerobic exercise sessions/week. From weeks 9-12, the participants will have only 1 supervised session/week and will be asked to complete at least 4 unsupervised aerobic exercise sessions/week. In total, the participants will be required to complete 150 minutes of moderate physical activity/week.

Also known as: Exercise, Aerobic Exercise
Moderate Intensity Aerobic Exercise

The wait list/usual care group will continue with their usual standard treatment (Medications +/- Psychotherapy) as before.

Also known as: Usual care, Care as usual, Standard Care
Moderate Intensity Aerobic ExerciseWait List/Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being sedentary (exercising less than 3 times/week for \> 20 minutes at moderate/vigorous intensity for each bout)
  • Ability to come for supervised exercises up to 5 days/week.
  • On stable doses of medication or psychotherapy (within last 1 month) for underlying depression and willingness to continue on stable dose or therapy schedule during active phase of study participation, with the exception of during acute exacerbation of symptoms of psychiatric illness.
  • Being able to read, understand, and provide written informed consent.

You may not qualify if:

  • DSM-IV TR Axis I diagnosis of bipolar disorder, schizophrenia or schizophrenia spectrum disorder, or substance or alcohol abuse/dependence disorder (except nicotine dependence) in the past 12 months. Patients with current primary anxiety disorder will also be excluded.
  • Behavioral or personality disturbances, which may significantly interfere with study participation.
  • Evidence of acute suicidal risk.
  • Medical contraindication for physical exercise (significant orthopedic or cardiopulmonary disorder) that would prevent regular aerobic exercise. The American College of Sports Medicine criteria for risk stratification will be used and where indicated medical clearance for exercise will be obtained through the subject's primary care physician.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Treatment-ResistantMotor Activity

Interventions

ExerciseWaiting ListsStandard of Care

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaAppointments and SchedulesOrganization and AdministrationHealth Services AdministrationQuality Indicators, Health CareQuality of Health CareHealth Care Quality, Access, and Evaluation

Study Officials

  • Ravi Singareddy, MD

    Penn State Univ. College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Proffesor

Study Record Dates

First Submitted

June 23, 2011

First Posted

June 28, 2011

Study Start

June 1, 2011

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

March 6, 2014

Record last verified: 2014-03

Locations